Form D · Other Health Care
Theragen, Inc.
Manassas, VA · CIK 0001683222
Offering snapshot reported Jun 21, 2017 · SEC filing
- Reported sold
- $1.25M Offering amount: $2.25M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2017 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
| Feb 23, 2017 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
| Aug 31, 2016 | Initial | $7,892,652 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-289133
Source: Form D, filed Jun 21, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jan A. Buck | Director |
| Kimball Chen | Director |
| Alex W. Evans | Director |
| Frithjof Fuchs | Director |
| Gary Grenter | Director, Executive |
| Jon Christopher Mc Auliffe | Executive |
| Matthew Rice | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11220 Assett Loop Suite 101
Manassas, VA, 20109
Manassas, VA, 20109